{{Rsnum
|rsid=271738
|Chromosome=1
|position=234527144
|Orientation=plus
|GMAF=0.3586
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.8 | 48.6 | 40.5
| HCB | 90.5 | 9.5 | 0.0
| JPT | 95.6 | 4.4 | 0.0
| YRI | 65.1 | 28.8 | 6.2
| ASW | 42.1 | 43.9 | 14.0
| CHB | 90.5 | 9.5 | 0.0
| CHD | 89.0 | 10.1 | 0.9
| GIH | 55.4 | 41.6 | 3.0
| LWK | 50.0 | 38.2 | 11.8
| MEX | 51.7 | 27.6 | 20.7
| MKK | 51.3 | 36.5 | 12.2
| TSI | 14.7 | 52.9 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=A
|Pval=0.000005
|OR=1.3200
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}